Stocks Overview

LAST PRICE
10.1000
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
10.1000/ 3
Ask / Lots
10.1800/ 4
Open / Previous Close
0.0000 / 10.1000
Day Range
---
52 Week Range
Low 4.9700
High 23.0000
Volume
---
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 10.08
Time	Volume	RDUS
09:32 ET	14131	10.14
09:34 ET	1699	10.16
09:36 ET	3133	10.16
09:38 ET	2433	10.18
09:39 ET	3459	10.16
09:41 ET	3038	10.165
09:43 ET	11716	10.13
09:45 ET	20585	10.1
09:48 ET	5470	10.1
09:50 ET	4917	10.12
09:52 ET	20290	10.13
09:54 ET	3361	10.11
09:56 ET	2579	10.125
09:57 ET	6816	10.13
09:59 ET	1973	10.15
10:01 ET	4905	10.12
10:03 ET	6139	10.14
10:06 ET	1930	10.14
10:08 ET	24900	10.155
10:10 ET	3000	10.155
10:12 ET	1800	10.13
10:14 ET	2600	10.13
10:15 ET	2428	10.1401
10:17 ET	1645	10.145
10:19 ET	400	10.145
10:21 ET	500	10.145
10:24 ET	315	10.15
10:26 ET	1300	10.155
10:28 ET	3800	10.145
10:30 ET	1900	10.135
10:32 ET	306	10.14
10:33 ET	2576	10.15
10:35 ET	300	10.16
10:37 ET	800	10.14
10:39 ET	737	10.15
10:42 ET	600	10.155
10:44 ET	1199	10.14
10:46 ET	26200	10.17
10:48 ET	3361	10.165
10:50 ET	1400	10.165
10:51 ET	1601	10.16
10:53 ET	2066	10.14
10:55 ET	1536	10.14
10:57 ET	1200	10.14
11:00 ET	3960	10.145
11:02 ET	1916	10.145
11:04 ET	1693	10.135
11:06 ET	300	10.14
11:08 ET	1400	10.14
11:09 ET	1300	10.14
11:11 ET	3016	10.135
11:13 ET	1200	10.13
11:15 ET	964	10.135
11:18 ET	300	10.13
11:20 ET	1041	10.13
11:22 ET	300	10.135
11:24 ET	926	10.14
11:26 ET	400	10.13
11:27 ET	400	10.135
11:29 ET	328	10.135
11:31 ET	1272	10.125
11:33 ET	911	10.12
11:36 ET	100	10.125
11:38 ET	200	10.12
11:40 ET	1004	10.12
11:42 ET	600	10.125
11:44 ET	934	10.12
11:45 ET	2345	10.11
11:47 ET	1712	10.1112
11:49 ET	800	10.11
11:51 ET	800	10.11
11:54 ET	800	10.11
11:56 ET	2038	10.11
11:58 ET	501	10.11
12:00 ET	10284	10.11
12:02 ET	800	10.11
12:03 ET	24429	10.1
12:05 ET	2306	10.11
12:07 ET	1812	10.11
12:09 ET	800	10.1105
12:12 ET	1935	10.115
12:14 ET	2049	10.1
12:16 ET	2400	10.105
12:18 ET	5415	10.105
12:20 ET	1000	10.11
12:21 ET	254	10.105
12:23 ET	3780	10.115
12:25 ET	2400	10.11
12:27 ET	1532	10.11
12:32 ET	1116	10.115
12:34 ET	500	10.12
12:36 ET	501718	10.115
12:38 ET	100500	10.115
12:39 ET	1501	10.11
12:41 ET	6709	10.11
12:43 ET	400	10.115
12:45 ET	1300	10.11
12:48 ET	300	10.115
12:50 ET	2013	10.11
12:52 ET	161015	10.105
12:54 ET	200	10.11
12:56 ET	36452	10.105
12:57 ET	122387	10.09
12:59 ET	1718	10.09
01:01 ET	777	10.09
01:03 ET	500	10.095
01:06 ET	89730	10.095
01:08 ET	1750	10.0907
01:10 ET	611	10.095
01:12 ET	3062	10.095
01:14 ET	2258	10.105
01:15 ET	4706	10.1
01:17 ET	1100	10.1
01:19 ET	9038	10.09
01:21 ET	11259	10.1
01:24 ET	637	10.095
01:26 ET	600	10.095
01:28 ET	1830	10.09
01:30 ET	1600	10.095
01:32 ET	56092	10.085
01:33 ET	2191	10.085
01:35 ET	1072	10.085
01:37 ET	2967	10.08
01:39 ET	200	10.08
01:42 ET	962	10.08
01:44 ET	16655	10.09
01:46 ET	1743295	10.09
01:48 ET	9739	10.09
01:50 ET	315	10.095
01:51 ET	692	10.1
01:53 ET	2100	10.095
01:55 ET	1220	10.095
01:57 ET	697	10.092
02:00 ET	600	10.09
02:02 ET	1181	10.095
02:04 ET	1500	10.09
02:06 ET	1724	10.09
02:08 ET	1945	10.095
02:09 ET	500	10.09
02:11 ET	242	10.095
02:13 ET	400	10.09
02:15 ET	100	10.09
02:18 ET	1101	10.09
02:20 ET	2428	10.09
02:22 ET	600	10.095
02:24 ET	1415	10.09
02:26 ET	1100	10.09
02:27 ET	1700	10.09
02:29 ET	300	10.09
02:31 ET	400	10.09
02:33 ET	300	10.09
02:36 ET	1300	10.095
02:38 ET	200	10.09
02:40 ET	401	10.09
02:42 ET	2500	10.09
02:44 ET	949	10.09
02:45 ET	1300	10.1
02:47 ET	600	10.09
02:49 ET	778	10.1
02:51 ET	21100	10.1
02:54 ET	928	10.1
02:56 ET	1200	10.09
02:58 ET	686	10.09
03:00 ET	800	10.09
03:02 ET	1900	10.095
03:03 ET	535	10.09
03:05 ET	800	10.1
03:07 ET	1200	10.09
03:09 ET	700	10.09
03:12 ET	819	10.09
03:14 ET	700	10.09
03:16 ET	300	10.095
03:18 ET	1206	10.095
03:20 ET	3060	10.09
03:21 ET	800	10.09
03:23 ET	1767	10.09
03:25 ET	927	10.09
03:27 ET	700	10.09
03:30 ET	2493	10.09
03:32 ET	1300	10.09
03:34 ET	2890	10.095
03:36 ET	411	10.095
03:38 ET	800	10.1
03:39 ET	630	10.09
03:41 ET	111	10.095
03:43 ET	2612	10.0916
03:45 ET	1200	10.09
03:48 ET	9996	10.09
03:50 ET	3433	10.095
03:52 ET	3800	10.09
03:54 ET	3329	10.095
03:56 ET	83663	10.115
03:57 ET	108746	10.115
03:59 ET	220686	10.1

Data delayed at least 15 minutes.

Yesterday
- BRIEF-Menarini Group's Elacestrant granted priority review by the U.S. FDA for patients with Er+/Her2- advanced or metastatic breast cancer, from 6:58AM ET on Thursday Aug 11, 2022 by Thomson Reuters
  6:58AM ET on Thursday Aug 11, 2022 by Thomson Reuters
- Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer, from 6:42AM ET on Thursday Aug 11, 2022 by PR Newswire
  6:42AM ET on Thursday Aug 11, 2022 by PR Newswire
- Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer, from 6:42AM ET on Thursday Aug 11, 2022 by CNW Group
  6:42AM ET on Thursday Aug 11, 2022 by CNW Group
Aug 2, 2022
- BRIEF-Radius Health And Teijin Pharma Entered Into Amendment To License & Development Agreement, from 4:38PM ET on Tuesday Aug 02, 2022 by Thomson Reuters
  4:38PM ET on Tuesday Aug 02, 2022 by Thomson Reuters
Jul 15, 2022
- SHAREHOLDER ALERT: Halper Sadeh LLP Investigates RDUS, ZEN, EPZM, RFP, from 12:00AM ET on Friday Jul 15, 2022 by Accesswire
  12:00AM ET on Friday Jul 15, 2022 by Accesswire

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRDUS Radius Health Inc	479.8M	-7.0x	---
United StatesMDXG MiMedx Group Inc	474.9M	-16.1x	---
United StatesKPTI Karyopharm Therapeutics Inc	415.0M	-3.7x	---
United StatesAMYT Amryt Pharma PLC	620.8M	-86.0x	---
United StatesVNDA Vanda Pharmaceuticals Inc	596.7M	54.0x	---
United StatesPBYI Puma Biotechnology Inc	162.6M	-4.1x	---
As of 2022-08-12

Radius Health, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing endocrine therapeutics. Its lead product, TYMLOS (abaloparatide) injection, is a prescription medicine for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Company also has products in clinical pipeline, which includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; an investigational abaloparatide patch for potential use in the treatment of postmenopausal women with osteoporosis; the investigational drug, elacestrant (RAD1901), for potential use in the treatment of hormone-receptor positive breast cancer out-licensed to Menarini Group, and RAD011, a synthetic cannabidiol oral solution that is being developed for the treatment of Prader-Willi syndrome (PWS).

Contact Information

Headquarters: Attn: Principal Finance Officer 22 Boston Wharf Road, 7Th FloorBOSTON, MA, United States 02210
Phone: 617-551-4000
Fax: 617-551-4701

Executives

Independent Chairman of the Board: Owen Hughes
President, Chief Executive Officer, Director: G. Kelly Martin
Chief Financial Officer, Vice President, Treasurer: Mark Conley
Senior Vice President , Chief Business Officer: Chhaya Shah
Vice President of Sales: Danielle Holtschlag

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

Fundamentals Table
Market Cap	$479.8M
Revenue (TTM)	$223.4M
Shares Outstanding	47.6M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.51
EPS	$-1.45
Book Value	$-5.33
P/E Ratio	-7.0x
Price/Sales (TTM)	2.1
Price/Cash Flow (TTM)	---
Operating Margin	-22.71%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Radius Health Inc
NASDAQ:RDUSUnited States

Search Criteria

Charts

Recent News

Yesterday

BRIEF-Menarini Group's Elacestrant granted priority review by the U.S. FDA for patients with Er+/Her2- advanced or metastatic breast cancer, from 6:58AM ET on Thursday Aug 11, 2022 by Thomson Reuters

Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer, from 6:42AM ET on Thursday Aug 11, 2022 by PR Newswire

Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer, from 6:42AM ET on Thursday Aug 11, 2022 by CNW Group

Aug 2, 2022

BRIEF-Radius Health And Teijin Pharma Entered Into Amendment To License & Development Agreement, from 4:38PM ET on Tuesday Aug 02, 2022 by Thomson Reuters

Jul 15, 2022

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates RDUS, ZEN, EPZM, RFP, from 12:00AM ET on Friday Jul 15, 2022 by Accesswire

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar